Mologic recently announced that it will transition into a social enterprise through the support of a group of philanthropic funds and investors led by the Soros Economic Development Fund, with support from the Bill & Melinda Gates Foundation. The investors that are part of the newly launched Global Access Health (GAH) are spending £30 million […]
Genomics/Molecular Diagnostics
COVID-19 testing boosts Abbott in Street-beating Q2
Abbott (NYSE:ABT) shares took a small dip despite second-quarter results that topped the consensus forecast. The Abbott Park, Ill.-based company posted profits of $1.2 billion, or 66¢ per share, on sales of $10.2 billion for the three months ended June 30, 2021, for a more-than doubled bottom-line on sales growth of 39.5%. Adjusted to exclude […]
Sherlock Biosciences names new CEO
Sherlock Biosciences announced today it appointed Bryan Dechairo as its president and CEO and he will join the company’s board. Dechairo will succeed co-founder Rahul Dhanda, who will continue to serve as a board member until the end of 2021, after which he will assume the role of strategic adviser in 2022. He joins Cambridge, […]
Eurofins, Rite Aid launch OTC at-home COVID-19 test in U.S.
Eurofins, its empowerDX subsidiary and Rite Aid announced the launch of an over-the-counter, at-home COVID-19 PCR test kit. Luxembourg-based Eurofins’ co-branded kits will be made available at all Rite Aid locations across 17 U.S. states, offering both symptomatic and asymptomatic users a way to test for COVID-19 at home, according to a news release. Eurofins […]
Abbott laying off hundreds of workers as COVID-19 testing demand drops
Abbott (NYSE:ABT) is reportedly laying off as many as 400 workers in Maine as a result of a drop in demand for its COVID-19 diagnostics. WMTW-TV in Portland, Maine reported that about 300 Abbott employees will be laid off in Westbrook, as confirmed by the town’s mayor. Additionally, the station reported that about 100 workers […]
Lumos Diagnostics raises $46.8M in Australian IPO
Lumos Diagnostics announced today that it raised $46.8 million ($63 million AUD) in an initial public offering in Australia. Sarasota, Fla.-based Lumos (which has its corporate head offices in Melbourne, Australia), a fully integrated developer and manufacturer of custom point-of-care diagnostic tests, was admitted to the Australian Securities Exchange (ASX) with trading commencing after July […]
Eurofins launches COVID-19 testing network to facilitate European travel
Eurofins announced today that it opened a network of about 500 COVID-19 testing centers across Europe to help facilitate summer travel. Luxembourg-based Eurofins’ network covers major traveling hubs to provide testing accessibility in locations ranging from supermarkets to business parks and residential areas, too. According to a news release, the company’s 500-center network is already […]
Abbott wins CE mark to sell Panbio COVID-19 antigen test over the counter
Abbott (NYSE:ABT) announced today that it received CE mark approval to market the Panbio COVID-19 test for over-the-counter use. European approval covers the direct-to-consumer sale of the Panbio COVID-19 antigen self-test for detecting the SARS-CoV-2 virus in adults and children both with or without symptoms. Abbott Park, Ill.-based Abbott’s Panbio antigen self-test uses a minimally […]
Hologic completes $795M Mobidiag acquisition
Hologic (NSDQ:HOLX) today announced that it has completed its $795 million acquisition of diagnostic developer Mobidiag Oy. France-based Mobidiag develops PCR-based tests for acute care conditions, including gastrointestinal and respiratory infections, antimicrobial resistance management and healthcare-associated infections. Its Amplidiag and Novodiag platforms can deliver results in 50 minutes to two hours. Marlborough, Mass.-based Hologic announced the […]
Amazon wins EUA to sell its COVID-19 test directly to consumers
Amazon subsidiary STS Lab Holdco received FDA emergency use authorization (EUA) for the direct-to-consumer sale of its COVID-19 test. The FDA authorized the test with indications as a direct-to-consumer product for testing individual anterior nasal swab specimens self-collected at home with the Amazon COVID-19 test collection kit DTC by any individual 18 years or older, […]
Abbott, Walgreens partner on boosting COVID-19 testing in Philadelphia
Abbott (NYSE:ABT) and Walgreens announced a pilot program designed to increase access to rapid COVID-19 testing in Philadelphia. Under the newly formed partnership, Pennsylvania Electronic Benefit Transfer (EBT) cardholders in Philadelphia will be able to receive Abbott’s BinaxNOW COVID-19 antigen self-tests weekly at no cost, according to a news release. Customers can visit any of […]
